Introduction
Historic perspectives on the relative contributions of diastolic and systolic blood pressure elevation to cardiovascular risk profile
Elevated systolic blood pressure and risk of cardiovascular and renal disease: Overview of evidence from observational epidemiologic studies and randomized controlled trials
Influence of arterial pulse and reflected waves on blood pressure and cardiac function
Risk reduction associated with lowering systolic blood pressure: Review of clinical trial data
Current clinical practice in hypertension: The EISBERG (Evaluation and Interventions for Systolic Blood Pressure Elevation-Regional and Global) project
Safety and efficacy of eprosartan, a new angiotensin II receptor blocker
Pharmacology of eprosartan, an angiotensin II receptor antagonist: Exploring hypotheses from clinical data
Integrated approaches to management of hypertension: Promoting treatment acceptance
Assimilating new therapeutic interventions into clinical practice: How does hypertension compare with other therapeutic areas?